Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v2-FR | Version v2-FR | |
---|---|---|
Language | French | French |
Date Updated | 2020-06-22 | 2020-06-22 |
Drug Identification Number | 02245918 | 02245918 |
Brand name | SANDOZ DILTIAZEM T | SANDOZ DILTIAZEM T |
Common or Proper name | SANDOZ DILTIAZEM T | SANDOZ DILTIAZEM T |
Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
Ingredients | DILTIAZEM HYDROCHLORIDE | DILTIAZEM HYDROCHLORIDE |
Strength(s) | 120MG | 120MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL ORAL | ORAL ORAL |
Packaging size | 100 PRCH BO | 100 PRCH BO |
ATC code | C08DB | C08DB |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for discontinuation | Manufacturing issues | Manufacturing issues |
Anticipated discontinuation date | ||
Actual discontinuation date | 2020-06-19 | 2020-06-19 |
Remaining supply date | 2020-06-19 | 2020-06-19 |
Discontinuation status | Discontinued | Discontinued |
Discontinuation decision reversal | no | no |
Tier 3 Status | No | No |
Information on remaining supply | ||
Company comments | ||
Health Canada comments |